# SkinHealth Systems Inc. (SKIN)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/skinhealth-systems-inc/ JSON: https://steadybase.io/company/skinhealth-systems-inc.json Checked Nov 10, 2026. Latest filing read: Nov 5, 2026.

## Company

- Legal name: SkinHealth Systems Inc.
- Ticker: SKIN (Nasdaq)
- SEC CIK: 0001818093
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: Long Beach, CA
- Fiscal year ends: December 31
- SEC filer category: Accelerated filer
- Website: beautyhealth.com
- LinkedIn: https://www.linkedin.com/company/beautyhealthco
- Next earnings date: Feb 4, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $300.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/0001628280-26-017376-index.html
- Operating income: -$20.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/0001628280-26-017376-index.html
- Net income: -$9.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/0001628280-26-017376-index.html
- SG&A: $211.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/0001628280-26-017376-index.html
- Employees: 613 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm
- Shares outstanding: 6,542,468 as of Nov 2, 2026 (10-Q filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026071173/0001628280-26-071173-index.html
- Auditor: Deloitte & Touche LLP, Los Angeles, California, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm

## Business

The Beauty Health Company (the “Company” or “we”) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $300.8M | -$20.8M | -$9.5M | $211.5M |
| Dec 31, 2024 | $334.3M | -$67.8M | -$29.1M | $243.8M |
| Dec 31, 2023 | $398.0M | -$130.9M | -$100.1M | $275.9M |
| Dec 31, 2022 | $365.9M | -$25.8M | $44.2M | $266.2M |
| Dec 31, 2021 | $260.1M | -$39.9M | -$378.8M | $210.3M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/skinhealth-systems-inc.json

## Officers and directors

- Pedro Bruno Ferreira Malha, President and CEO. Source: Form 4 filed Mar 24, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026020850/0001628280-26-020850-index.htm
- Michael Monahan, Chief Financial and Operating Officer. Source: 8-K filed Sep 10, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026061326/skin-20260903.htm
- Michael P. Monahan, Chief Financial Officer. Source: Form 4 filed Aug 12, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026056277/0001628280-26-056277-index.htm
- Brian Miller, Director. Source: 10-K filed Mar 12, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm
- Desiree Gruber, Director. Source: 10-K filed Mar 12, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm
- Doug Schillinger, Director. Source: 10-K filed Mar 12, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm
- Michelle Kerrick, Director. Source: 10-K filed Mar 12, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm
- Philippe Schaison, Director. Source: 10-K filed Mar 12, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm
- Stephen J. Fanning, Director. Source: 10-K filed Mar 12, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm
- Brenton L. Saunders, Board member (per proxy). Source: DEF 14A filed Aug 12, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000168316826006273/skinhealth_def14a.htm
- Kenneth Tripp, Board member (per proxy). Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1818093/000168316826003189/skinhealth_idef14a.htm

## Recent 8-K events

- Nov 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026071066/skin-20261105.htm
- Oct 14, 2026: Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026065833/skin-20261014.htm
- Oct 6, 2026: Item 1.02, Termination of a material definitive agreement; Item 7.01, Regulation FD disclosure. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026065232/skin-20260930.htm
- Sep 28, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026063712/skin-20260922.htm
- Sep 10, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026061326/skin-20260903.htm
- Aug 14, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026057096/skin-20260810.htm
- Aug 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026054309/skin-20260806.htm
- Jun 22, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026044620/skin-20260617.htm
- Jun 16, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026043539/skin-20260610.htm
- May 12, 2026: Item 3.01, Notice of delisting or failure to meet listing standards. Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026034101/skin-20260508.htm

## What management said

- "Our third quarter results reflect encouraging progress in strengthening our business. Revenue trends improved, consumables returned to growth, and we delivered healthy adjusted EBITDA performance. While we have more work ahead, these results give us greater confidence that the actions we are taking are moving the business in the right direction" Pedro Malha, President and Chief Executive Officer of SkinHealth Systems (8-K filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1818093/000162828026071066/ex991-2026q3xearnings.htm

## Latest filings

- 8-K filed Oct 14, 2026: https://www.sec.gov/Archives/edgar/data/1818093/000162828026065833/skin-20261014.htm
- 10-K filed Mar 12, 2026: https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm
- 10-Q filed Aug 6, 2026: https://www.sec.gov/Archives/edgar/data/1818093/000162828026054476/skin-20260630.htm
- DEF 14A filed Aug 12, 2026: https://www.sec.gov/Archives/edgar/data/1818093/000168316826006273/skinhealth_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/